260 related articles for article (PubMed ID: 33155344)
41. An Endoplasmic Reticulum Targeting Type I Photosensitizer for Effective Photodynamic Therapy against Hypoxic Tumor Cells.
Li S; Chen Y; Wu Y; Yao S; Yuan H; Tan Y; Qi F; He W; Guo Z
Chemistry; 2022 Dec; 28(72):e202202680. PubMed ID: 36170107
[TBL] [Abstract][Full Text] [Related]
42. BODIPY-doped silica nanoparticles with reduced dye leakage and enhanced singlet oxygen generation.
Wang Z; Hong X; Zong S; Tang C; Cui Y; Zheng Q
Sci Rep; 2015 Jul; 5():12602. PubMed ID: 26211417
[TBL] [Abstract][Full Text] [Related]
43. Elsinochrome A induces cell apoptosis and autophagy in photodynamic therapy.
Yao Y; Pan L; Song W; Yuan Y; Yan S; Yu S; Chen S
J Cell Biochem; 2023 Sep; 124(9):1346-1365. PubMed ID: 37555580
[TBL] [Abstract][Full Text] [Related]
44. Copper(II)-Graphitic Carbon Nitride Triggered Synergy: Improved ROS Generation and Reduced Glutathione Levels for Enhanced Photodynamic Therapy.
Ju E; Dong K; Chen Z; Liu Z; Liu C; Huang Y; Wang Z; Pu F; Ren J; Qu X
Angew Chem Int Ed Engl; 2016 Sep; 55(38):11467-71. PubMed ID: 27504861
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of Nanoparticles Covalently Bound with BODIPY for Their Photodynamic Therapy Applicability.
Malacarne MC; Caruso E; Gariboldi MB; Marras E; Della Bitta G; Santoro O; Simm A; Li R; Ferguson CTJ
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542161
[TBL] [Abstract][Full Text] [Related]
46. Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic Prostate Cancer Therapy.
Hu J; Luo H; Qu Q; Liao X; Huang C; Chen J; Cai Z; Bao Y; Chen G; Li B; Cui W
ACS Appl Mater Interfaces; 2020 Sep; 12(38):42511-42520. PubMed ID: 32897691
[TBL] [Abstract][Full Text] [Related]
47. Expanding the Limits of Photodynamic Therapy: The Design of Organelles and Hypoxia-Targeting Nanomaterials for Enhanced Photokilling of Cancer.
Calori IR; Bi H; Tedesco AC
ACS Appl Bio Mater; 2021 Jan; 4(1):195-228. PubMed ID: 35014281
[TBL] [Abstract][Full Text] [Related]
48. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic enhancement of vascular-targeted photodynamic therapy by inhibiting proteasomal function.
Li Z; Agharkar P; Chen B
Cancer Lett; 2013 Oct; 339(1):128-34. PubMed ID: 23872275
[TBL] [Abstract][Full Text] [Related]
50. Enhanced photodynamic efficiency of an aptamer-guided fullerene photosensitizer toward tumor cells.
Liu Q; Xu L; Zhang X; Li N; Zheng J; Guan M; Fang X; Wang C; Shu C
Chem Asian J; 2013 Oct; 8(10):2370-6. PubMed ID: 23907978
[TBL] [Abstract][Full Text] [Related]
51. Self-Rectifiable and Hypoxia-Assisted Chemo-Photodynamic Nanoinhibitor for Synergistic Cancer Therapy.
Wang Y; Huo J; Li S; Huang R; Fan D; Cheng H; Wan B; Du Y; He H; Zhang G
ACS Appl Mater Interfaces; 2022 Mar; 14(8):10092-10101. PubMed ID: 35170301
[TBL] [Abstract][Full Text] [Related]
52. Reactive Reductive Species Participating Photodynamic Therapy for Cancer Treatment.
Peng J; Feng F
Chemistry; 2024 Jan; 30(1):e202302842. PubMed ID: 37750352
[TBL] [Abstract][Full Text] [Related]
53. DNA directed damage using a brominated DAPI derivative.
Digby EM; Rana R; Nitz M; Beharry AA
Chem Commun (Camb); 2019 Aug; 55(67):9971-9974. PubMed ID: 31367709
[TBL] [Abstract][Full Text] [Related]
54. An intelligent dual stimuli-responsive photosensitizer delivery system with O
Zhao H; Li L; Zheng C; Hao Y; Niu M; Hu Y; Chang J; Zhang Z; Wang L
Colloids Surf B Biointerfaces; 2018 Jul; 167():299-309. PubMed ID: 29679806
[TBL] [Abstract][Full Text] [Related]
55. Modulating mitochondrial morphology enhances antitumor effect of 5-ALA-mediated photodynamic therapy both in vitro and in vivo.
Zhao H; Yin R; Wang Y; Lee YH; Luo T; Zhang J; Qiu H; Ambrose S; Wang L; Ren J; Yao J; Chen D; Wang Y; Liang Z; Zhen J; Wu S; Ye Z; Zeng J; Huang N; Gu Y
J Photochem Photobiol B; 2017 Nov; 176():81-91. PubMed ID: 28964889
[TBL] [Abstract][Full Text] [Related]
56. Cu
Su Z; Xu H; Zhang H; Jin S; Yang Z; Yan R; Wang Z; Wu X; Jin Y
Bioconjug Chem; 2023 Jul; 34(7):1336-1347. PubMed ID: 37343132
[TBL] [Abstract][Full Text] [Related]
57. Fluorinated polymeric micelles to overcome hypoxia and enhance photodynamic cancer therapy.
Wang Q; Li JM; Yu H; Deng K; Zhou W; Wang CX; Zhang Y; Li KH; Zhuo RX; Huang SW
Biomater Sci; 2018 Oct; 6(11):3096-3107. PubMed ID: 30306153
[TBL] [Abstract][Full Text] [Related]
58. Self-delivery nanomedicine for chemotherapy sensitized photodynamic therapy.
Liu L; Zhou X; Zheng R; Huang J; Kong R; Li Y; Wang C; Chen A; Li S; Cheng H
Chem Commun (Camb); 2021 Jul; 57(59):7296-7299. PubMed ID: 34223569
[TBL] [Abstract][Full Text] [Related]
59. Photophysical properties and photodynamic therapy activities of detonated nanodiamonds-BODIPY-phthalocyanines nanoassemblies.
Matshitse R; Ngoy BP; Managa M; Mack J; Nyokong T
Photodiagnosis Photodyn Ther; 2019 Jun; 26():101-110. PubMed ID: 30851436
[TBL] [Abstract][Full Text] [Related]
60. A Light-Triggered J-Aggregation-Regulated Therapy Conversion: from Photodynamic/Photothermal Therapy to Long-Lasting Chemodynamic Therapy for Effective Tumor Ablation.
Wei K; Wu Y; Zheng X; Ouyang L; Ma G; Ji C; Yin M
Angew Chem Int Ed Engl; 2024 Jun; 63(23):e202404395. PubMed ID: 38577995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
